boots group plc preliminary results 2004/05 19 th may 2005
TRANSCRIPT
Boots Group PLCPreliminary Results 2004/05
19th May 2005
Sir Nigel RuddChairman
Richard BakerChief Executive
Agenda
• Financial Review
• Operational Review
• The next phase - clear priorities and focus
Jim SmartActing Chief Financial Officer
Group results
12 months to 31st March 2005 (£m) Sales Profit
Boots The Chemists4,65
1 +3.8% 470 - 11.8%
Boots Healthcare International 523 +3.6% 88 +8.9%
Boots Opticians 183 - 8.6% 4 - 67.4%
Boots Retail International 48 +12.3% (8) +21.2%
Group & other costs 37 -37.9% (46) 0.0%
Discontinued operations 27 (7)
Group sales and operating profit5,46
9 +2.7% 501 -8.7%
Interest (20)
Profit before tax and exceptionals 481 -11.4%
Group results
12 months to 31st March 2004 2005
Exceptional items £36m£(54)
m
Effective tax rate 30.9% 29.6%
EPS - Basic 52.8p 40.9p - 22.5%
- Pre-exceptional 48.0p 45.7p - 4.8%
Dividend per share 29.8p 30.1p +1.0%
Dividend £226m £217m - 4.3%
Share repurchase £260m £300m
Boots The Chemists
- 11.8%470533Operating profit
-80bpGross margin movement
+2.4%+3.8%4,6514,479Sales
Like for Like
2005£m
2004£m
12 months to 31st March
-30bp
BTC sales growth
• Total Sales up 3.8%
• Lower prices and promotional activity reduced revenue by 4.8%– A further 2,000 lines reduced by 14% under LPYL
• Volumes up 4.6%– New space– Extended opening hours– Better value
• Mix of products sold contributed 4.0%
BTC transaction numbers
£9.21£9.19Average Transaction Value
+0.2%+5.4%− Growth
+3.0%- 1.4%− Total
+1.5%
2005
- 2.0%− Like for like stores
Counter Transactions growth
200412 months to 31st March
Underlying NHS items growth 3.5% 5.2%
Weekly footfall 19.3m 19.8m
BTC sales by category
• Health £1,863m, +5.0%– Strong items growth in Dispensing– Vitamins and new OTC products
• Beauty & Toiletries £2,055m, +2.9%– Continued strong growth in Beauty– Toiletries remains very competitive but market share maintained
• Lifestyle £734m, +3.7%– Extended Baby ranges– Food ranges re-launched– Continued decline in Photo market
BTC gross margin
• Gross margin down 80bps
• 260bps impact of lower prices– Pricing and promotions– LPYL impact 150bps
• 180bps recovered through better buying, manufacturing efficiencies and mix
BTC operating costs
12 months to 31st March (£m
increase) 2005
Inflation 40
Volume 20
Productivity / GiS (90)
(30)
Pension 15
Existing stores/trading 45
IT Infrastructure/tills 35
New space/formats 35
YoY cost increase 100 +7%
BTC operating costs
12 months to 31st March (£m
increase) 2005 2006
Inflation 40 50
Volume 20 10
Productivity / GiS (90) (70)
(30) (10)
Pension 15 15
Existing stores/trading 45 40
IT Infrastructure/tills 35 25
New space/formats 35 30
YoY cost increase 100 +7% 100 +6%
Capital expenditure
12 months to 31st March (£m) 2005 2006
Group
Capital expenditure 288 200
Depreciation charge 146 190
Boots The Chemists
Capital expenditure 225 150
Depreciation charge 100 130
Getting in Shape update
• Cumulative programme savings of £111m (05/06 vs 02/03)– Savings estimated at interims £132m
• Redundancies delayed to 06/07 • BHI actions cancelled
• Savings comprise– BTC Head Office costs reduced by £55m
• Head count reduced by 1,200– Manufacturing efficiencies of £52m
• BTC £35m• BHI £17m
– BHI operating costs reduced by £4m
Boots Healthcare International
12 months to 31st March2004
£m2005
£mLocal
currency
Sales 505 523 +3.6% +5.8%
Brand investment/sales 28% 27%
Operating profit 81 88 +8.9% +12.7%
BHI Sales by Brand
12 months to 31st March 2005
Sales
£m
Nurofen 150 +8.1%
Clearasil 91 +6.0%
Strepsils 91 +9.3%
Dermo-cosmetics 48 -6.6%
Other 143 +5.8%
Total 523 +5.8%
Sales growth relates to local currency
Update on planned sale of BHI
• Process on track
• Tax efficient disposal
• Completion within 05/06 financial year
• Significant proportion of proceeds to be returned to shareholders
Group cash flow
12 months to 31st March 2004£m
2005£m
Operating profit 550 501
Working capital (47) (118)
Capital expenditure (194) (304)
Depreciation 134 146
Operating cash flow 443 225
Disposal of fixed assets 150 21
Other items 0 (14)
Business cash flow 593 232
Working capital movements
12 months to 31st March (£m) 2004 Weeks
cover
2005 Weeks cover
Stock - Boots The Chemists (60) 11 (29) 11
- Other 6 8
(54) (21)
Debtors (43) (49)
Creditors
- Redundancy provision
41 (32)
- Staff bonus - (10)
- Other 9 (6)
50 (48)
(47) (118)
Balance Sheet
• Maintain strong investment grade debt rating
• Share buy back– £300m returned in 04/05– Commitment to return remainder of £700m programme over 2 to 3
years
• 730.5m shares in issue at 31st March 2005
• Net debt £594m, an increase of £446m
• Sale and leaseback process on track to complete over the Summer
Planning assumptions for 2005/06
• Sales growth expected to remain subdued– LFL growth 0 – 2%– New space contribution 2%
• Stable gross margin expected– Continued investment in price– Cost of Goods improvement
• Costs expected to be up 6% due to infrastructure renewal and new space
Summary
• Group profits lower due to the cost of modernising Boots The Chemists
• Boots The Chemists made good progress in key markets
• BHI disposal process on track
• Committed to returning cash to shareholders– Significant proportion of BHI sale proceeds– Completing remainder of £700m share buy back– Dividend a key element of delivering shareholder returns
• Full year guidance unchanged
Richard BakerChief Executive
Agenda
• Financial Review
• Operational Review
• The next phase - clear priorities and focus
Substantial progress has been made
Neglected core strengths Strong Pharmacy performanceBuilding strength in Beauty
Losing customersCompeting better in commodity markets
Gross margin broadly stable
Difficult to shopMore convenient and accessible stores
Outdated systems Inefficient operations Modern infrastructure
Unsustainable prices
Strong pharmacy performance
• Dispensing +6.1%– Best performance for 5 years
• Investing in the core of the business– 1,000 stores now have Smartscript– 80 pharmacies upgraded
• Greater convenience for customers– Prescription collection service +17%
• Developing new markets– Care home service +12%
Building on the strength in Beauty
• Cosmetics & Fragrance +5.3%
• Investing behind key strength– Successful re-launch of No7– 24 new beauty halls– New fragrance units in 178 stores
• Value for money– Advantage card– Competitive pricing in Fragrance
• Seasonal events better implemented
Competing better in commodity markets• Market share maintained
• Lower Prices You’ll Love– £200m invested in 18 months
• Promotions – Simpler, stronger offers
• Own brand innovation
Gross margin ahead of target
• Successful management of pricing/promotional mix
• £30m buying gains achieved in the year
• National brands– Higher volumes– Collaborative working
• Own brands– Getting in Shape– 3rd party sourcing
More convenient and accessible stores• Stores open when customers want to shop
– Local hours to suit local needs – 400 more stores open on Sundays and Bank Holidays
• Building space on the Edge of Town– 23 new stores taking total to 112– 15% of space now EoT – LFL stores in second year show +22% sales growth
Modern infrastructure
• Renewal of IT infrastructure– New tills in all stores– 100 stores now have Radio Frequency technology– 3 of 4 SAP Backbone phases now completed
• Store friendly supply chain– 82% of lines delivered direct to shelf– Lower stock holding in store
• Lower cost base in Nottingham– 1/3rd fewer jobs in Head office– Manufacturing
Our journey….The
next phase
Modern,Competitive,
Efficient
TheHealth & Beauty
Expert
Too expensiveUnder invested
“Old” Boots
Building a Better Boots
The next phase – clear focus and priorities
ExpertCustomer
Care
Right Stores,Right Places
Boots for Value
Only at Boots
HealthcareFirst
Driving efficiency
• Continuous process
• Better buying– Collaboration with suppliers– Cross category sourcing– Far East
• Supply chain– Lower stock holding in store
Healthcare First
• Unifying feature, strong brand heritage
• 40% of sales, 50% of profits
• Strong long term growth opportunity
• Deregulation
• Increasing role for community pharmacy
• Electronic Transfer of Prescriptions
Only at Boots
• Market leading own brand beauty products– No7 – 17 will be re-launched this year
• Market leading own brand toiletries– Soltan 5*– Smile to be re-launched
• Range authority– Premium cosmetics
• Exclusives on new launches– 20% on sales from items less than 1 year old
Boots for value
• Continued investment in value– Mitigated by sourcing gains and own brand mix
• Strong, simple offers
• Great rewards from Advantage Card– 14m active card holders– Invitation events– Boots Parenting Club
Right stores right places
• More stores on the Edge of Town– Good growth potential– Modern stores– Low cost model
• London’s best health & beauty store– Layout– Signage
Expert customer care
• Trusted brand
• Expert people
• Differentiated, specialist offer
Summary
• Substantial progress against our plans
• BTC remains a successful and profitable business
• Challenging environment
• Building a better Boots
• The Health & Beauty Expert
Boots Group PLCPreliminary Results 2004/05
Boots Group PLCPreliminary Results 2004/05 -Appendices
Sales Performance by category2004/05
SalesSales
GrowthLFL
Growth
Health £1,863m 5.0% 4.4%
− Dispensing 6.1%
− OTC Medicines 3.1%
Beauty & Toiletries £2,055m 2.9% 0.9%
− Cosmetics & Fragrance 5.3%
− Toiletries 0.1%
Lifestyle £734m 3.7% 1.6%
− Food 5.2%
− Baby 6.8%
− Photo -8.0%
Aggregate spend on modernising BTC in 2004/05 vs Original Plans communicated with preliminary results 2004
Actual Original Plan
Year ended 31 March 2005 (£m)
Revenue Capital Revenue Capital
Modern
Convenience 27 8 19 7
Faster Pharmacy 8 11 12 21
Right Places 18 45 31 69
Right Stores 25 66 38 71
Competitive – Only at Boots 8 30 10 26
Efficient
Making IT Easy 23 54 26 45
Store Friendly Supply Chain 7 11 4 11
116 225 140 250
Increase in operating costs as a result of revenue spend on modernising BTC£m 2003/
042004/0
52005/0
6
Revenue spend (per slide 46 for 04/05)
• recurring costs 44 90 46
• one-off costs 18 26 14
62 116 60
Full year impact of PY recurring costs 17 61
PY one-off costs not recurring (18) (26)
Increase in operating costs 115 95
Analysed in slide 14 as:
• Existing stores/trading 45 40
• IT Infrastructure/tills 35 25
• New space/formats 35 30
115 95
Getting in ShapeC
um
ula
tiv
e S
av
ing
s
vs
20
02
/03
£M
Co
sts
in
th
e y
ea
r
£M
100
50
0
50
100
150
22
66
34
31
83
111
BHI
554920-
Cumulative Savings 2005/062004/052003/042002/03
5
BTC – Operating costs
BTC – Cost of goods 35217-
21134-
Incremental Effect of Getting in Shape on PBT
£m 2004/05
2005/06
Getting in Shape Costs & Savings (from slide 48):
Costs incurred in the year (34) (5)
PY costs not recurring 66 34
Incremental savings 52 28
Incremental Effect on PBT vs PY 84 57
Analysed as:
• BTC – Operating costs (included in Productivity / GIS on slide 14)
64 19
• BTC – Cost of goods 14 14
• BHI 9 8
• Group & other / exceptional (3) 16
84 57
Implications of IFRS
• First IFRS reporting H1 2005/06
• Detailed impact to be provided in July
Balance Sheet at 31.03.05
OperatingProfit 04/05
£m
Assets£m
Liabilities£m
Net Assets
£m
IAS 19 Pensions (117) (19) (136) (18)
IAS 17 Leases 46 (57) (11) 5
IAS 12 Deferred Tax 61 (65) (4) -
IAS 10 Proposed Dividends
- 150 150 -
Other 4 1 5 2
Total Impact (6) 10 4 (11)